Antibiotic prophylaxis in prostate biopsy. A comparative randomized clinical assay between ciprofloxacin, norfloxacin and chloramphenicol

International Braz J Urol

Volumn 29, Issue 4, 2003, Pages 313-319

  Tobias Machado, M ^a   Corrêa, Thiago D ^a   De Barros, Emília L ^a   Wroclawski, Eric R ^a  

^a FACULDADE DE MEDICINA DO ABC   (Brazil)

Author keywords

Antibiotic prophylaxis; Biopsy; Needle; Prostate; Ultrasonography

Indexed keywords

ANTIBIOTIC AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; DIPYRONE; NORFLOXACIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTEREMIA; CHI SQUARE TEST; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEVER; FISHER EXACT TEST; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PROSTATE BIOPSY; PROSTATITIS; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; URINE RETENTION;

EID: 0141828956     PISSN: 16775538     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1677-55382003000400005     Document Type: Article

References (20)

1. Moon DG, Yu JW, Lee JG, Kim JJ, Koh SK, Cheon J: The influence of prostate volume on the prostate-specific antigen (PSA) level adjusted for the transition zone volume and free-to-total PSA ratio: a prospective study. BJU Int. 2000; 86: 670-4.
2. Machado MT, Pinto MA, Mattos MHE, Borrelli M, Wroclawski ER: Complications of prostatic biopsy with 10 fragments - analysis of 40 cases. Braz J Urol. 2001; 27 (supl 1): Abst. 541, 147. [in Portuguese]
3. Fong IW, Struthers N, Honey RJ, Simbul M, Boisseau DA: A randomized comparative study of the prophylactic use of trimethoprim- sulfamethoxazole versus netilmycin- metronidazole in transrectal prostatic biopsy. J Urol. 1991; 146: 794-7.
4. Lindgren PG: Percutaneous needle biopsy. A new technique Acta Radiol Diagn. 1982; 23: 653-6.
5. Enlund AL, Varenhorst E: Morbidity of ultrasound-guided transrectal core biopsy of the prostate without prophylactic antibiotic therapy. A prospective study in 414 cases. Brit J Urol. 1997; 79: 777-80.
6. Roach MB, Figueroa TE, McBride D, George WJ, Neal DE: Ciprofloxacin versus gentamicin in prophylaxis against bacteremia in transrectal prostate needle biopsy. Urology 1991; 38: 84-7.
7. Machado MT, Simardi LH, Pinto MA, Eiger A, Freitas JPA, Borrelli M, et al.: First campaign of prostatic health of ABC Medical School. Pathologic results of prostate needle biopsy. Arq Med ABC 2000; 23: 12-7.
8. Kapoor DA, Klimberg IW, Malek GH, Wegenke JD, Cox CE, Patterson AL, et al.: Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology 1998; 52: 552-8.
9. Borer A, Gilad J, Sikuler E, Riesenberg K, Schlaeffer F, Buskila D: Fatal Clostridium sordellii ischiorectal abscess with septicaemia complicating ultrasound-guided transrectal prostate biopsy. J Infect. 1999; 38: 128-9.
10. Nesi MH, Malloy TR, Carpiniello VL, Wein AJ: A comparison of morbidity following transrectal and transperineal prostatic needle biopsy. Surg Gynecol Obstet. 1983; 156: 464-6.
11. Taylor HM, Bingham JB: Antibiotic prophylactic for transrectal prostate biopsy. J Ant Chem. 1997; 39: 115-7.
12. Norberg M, Holmberg L, Häggman M, Magnusson A: Determinants of complications after multiple transrectal core biopsies of the prostate. Eur Radiol. 1996; 6: 457-61.
13. Aus G, Ahlgren G, Bergdahl S, Hugosson J: Infection after transrectal core biopsy of the prostate- risk factors and antibiotic prophylaxis. Br J Urol. 1996; 77: 851-5.
14. Shandera KC, Thibault GP, Deshon GE: Efficacy of one dose fluoroquinolone before prostate biopsy. Urology 1998; 52: 641-3.
15. Isen K, Küpeli B, Sinik Z, Sözen S, Bozkirli I: Antibiotic prophylaxis for transrectal biopsy of the prostate: a prospective randomized study of the prophylactic use of single dose oral fluoroquinolone versus trimethoprim-sulfamethoxazole. Int Urol Nephrol. 1999; 31: 491-5.
16. Aron M, Rajeev TP, Gupta NP: Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study. BJU Int. 2000; 85(6): 682-5.
17. Ornellas AA, Koifman N, Wisnescky A: Infeccion prophylaxis in patients submitted to transrectal prostatic biopsy. Clinical trial of efficacious of lomerfloxacin versus cefazolin. J Bras Urol. 1998; 24: 237-40. [in Portuguese]
18. Vaz F, Muglia R, Tostes H, Torres H: Use of lomerfloxacin in prophylaxis during transrectal prostatic biopsy. RBM Rev Bras Med. 1994; 51: 1709-10. [in Portuguese]
19. Brewster SF, MacGowan AP, Gingell JC: Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective randomized trial of cefuroxime versus piperacillin/ tazobactam. Br J Urol. 1995; 76: 351-4.
20. Machado T, Corrêa TD, Barros EL, Goldenstein PT, Kappaz GT, Fuganti PE, et al.: Critical analysis of prophylactic antibiotics use in transrectal prostatic biopsy: literature review. Diagn Trat. 2003; 8: 88-92. [in Portuguese]